Cryosupernatant
Cryosupernatant is a plasma product that is obtained from the thawing of frozen plasma. It is used in the treatment of certain medical conditions, such as thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS).
Preparation[edit | edit source]
Cryosupernatant is prepared by thawing frozen plasma at 1-6°C. The thawed plasma is then centrifuged to separate the cryoprecipitate, which contains high concentrations of fibrinogen, factor VIII, and von Willebrand factor. The remaining liquid portion is the cryosupernatant.
Uses[edit | edit source]
Cryosupernatant is used in the treatment of thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). It is also used in patients with coagulation disorders who require large volumes of plasma but do not need the high concentrations of fibrinogen and factor VIII found in cryoprecipitate.
Risks[edit | edit source]
As with any plasma product, there are risks associated with the use of cryosupernatant. These include the potential for transfusion reactions, infection, and volume overload.
See Also[edit | edit source]
Cryosupernatant Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD